Security National Bank of So Dak’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Hold
2,000
– – 0.28% 76
2026
Q1
$662K Hold
2,000
– – 0.32% 73
2025
Q4
$795K Hold
2,000
– – 0.39% 63
2025
Q3
$912K Hold
2,000
– – 0.46% 63
2025
Q2
$652K Hold
2,000
– – 0.36% 69
2025
Q1
$540K Hold
2,000
– – 0.31% 72
2024
Q4
$471K Hold
2,000
– – 0.26% 75
2024
Q3
$550K Hold
2,000
– – 0.31% 69
2024
Q2
$486K Hold
2,000
– – 0.29% 70
2024
Q1
$299K Hold
2,000
– – 0.18% 86
2023
Q4
$383K Hold
2,000
– – 0.25% 73
2023
Q3
$354K Hold
2,000
– – 0.26% 77
2023
Q2
$380K Buy
+2,000
New +$397K 0.27% 73
2022
Q4
$475K Hold
2,000
– – 0.34% 66
2022
Q3
$400K Hold
2,000
– – 0.36% 70
2022
Q2
$292K Hold
2,000
– – 0.24% 79
2022
Q1
$327K Buy
2,000
+500
+33% +$76.2K 0.23% 80
2021
Q4
$254K Hold
1,500
– – 0.17% 90
2021
Q3
$283K Buy
+1,500
New +$281K 0.22% 83
2021
Q2
– Sell
-1,500
Closed -$212K – 98
2021
Q1
$212K Buy
+1,500
New +$226K 0.18% 93
2020
Q4
– Sell
-1,500
Closed -$218K – 89
2020
Q3
$218K Hold
1,500
– – 0.22% 80
2020
Q2
$222K Buy
+1,500
New +$202K 0.25% 72
2017
Q4
– Sell
-2,100
Closed -$247K – 93
2017
Q3
$247K Buy
+2,100
New +$179K 0.28% 81

Other funds holding ALNY

Security National Bank of So Dak's ALNY Position: Q2 2026 in Review

Security National Bank of So Dak held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 2,000 shares worth $602K. The position accounts for 0.28% of the portfolio, ranked #76.

Security National Bank of So Dak first reported a position in ALNY in Q3 2017 and has held it in 23 quarters since. The position peaked at $912K in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Security National Bank of So Dak held 2,000 shares of Alnylam Pharmaceuticals worth $602K as of Q2 2026.
  • Security National Bank of So Dak left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.28% of Security National Bank of So Dak's portfolio in Q2 2026, its #76 holding.
  • Security National Bank of So Dak first reported a position in Alnylam Pharmaceuticals in Q3 2017 and has held it in 23 quarters since.
  • Security National Bank of So Dak's Alnylam Pharmaceuticals position peaked at $912K in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Security National Bank of So Dak's 13F filing for Q2 2026, filed 18 Sep 2026.